New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 22, 2016 – The FDA approved new updates to the Contraindications and Drug Interactions sections of the drug label for Kaletra (lopinavir/ritonavir) pertaining to the addition of new drugs.
Download PDF
Return to publications
